Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / MDXG - MiMedx concludes enrollment for Phase 3 plantar fasciitis trial


MDXG - MiMedx concludes enrollment for Phase 3 plantar fasciitis trial

  • MiMedx (OTCPK:MDXG -0.1%) has completed enrollment in its Phase 3 study of micronized dehydrated Human Amnion Chorion Membrane (dHACM) injection, for plantar fasciitis, an inflammation of the fibrous tissue along the bottom of the foot that results in intense pain.
  • More news on: MiMedx Group, Inc., Healthcare stocks news,
  • Read more ...
Stock Information

Company Name: MiMedx Group Inc
Stock Symbol: MDXG
Market: NASDAQ
Website: mimedx.com

Menu

MDXG MDXG Quote MDXG Short MDXG News MDXG Articles MDXG Message Board
Get MDXG Alerts

News, Short Squeeze, Breakout and More Instantly...